Clinical trial
A Clinical Trial Comparing Efficacy and Safety of Exubera® and Humalog®
NCT00356421 · Pfizer, Industry · Terminated
Key facts
| NCT number | NCT00356421 |
|---|---|
| Title | A Clinical Trial Comparing Efficacy and Safety of Exubera® and Humalog® |
| Official title | A 52-Week Multicenter, Open-Label, Randomized, Parallel, Two - Arm Study Comparing Exubera® (Inhaled Human Insulin) Vs. Humalog® (Insulin Lispro), Both In Combination With Insulin Glargine In Subjects With Type 1 Diabetes Mellitus |
| Lead sponsor | Pfizer, Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 1 |
| Intervention type | Drug |
| Interventions | Inhaled Human Insulin (Exubera®), Insulin lispro (Humalog) |
| Enrollment | 58 |
| Start date | Nov 1, 2006 |
| Primary completion | Jun 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Jul 26, 2006 |
| Last update posted | Sep 2, 2009 |
| Countries | Austria, Belgium, Denmark, Finland, France, Ireland, Netherlands, Norway, Portugal, Spain, Sweden, United Kingdom and 1 more |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: